Clinical Trials Browser

Phase 4 × Overweight × Exenatide × Clear all

NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

Phase 4 Completed

Obesity, Polycystic Ovary Syndrome, Overweight